Salvage stereotactic body radiotherapy in oligometastatic gynaecological cancer
Martina Midulla, Andrei Fodor, Flavia Zerbetto, Chiara Lucrezia Deantoni, Roberta Tummineri, Laura Giannini, Sara Broggi, Miriam Torrisi, Federica Ferrario, Chiara Chissotti, Stefano Lorenzo Villa, Paola Mangili, Claudio Fiorino, Stefano Arcangeli, Nadia Gisella Di Muzio | PD-0813 | ESTRO | 2023
Impact of the VOLO Optimizer on Treatment Plan Quality of Stereotactic Prostate Radiotherapy
T. Viren, J. Seppälä | PO-2052 | ESTRO | 2023
Stereotactic Radiotherapy of Prostate Cancer Patients – Two Techniques Comparison: Preliminary Results
Aleksandra Napieralska, Wojciech Majewski, Marcela Krzempek, Grzegorz Woźniak, Marcin Miszczyk, Małgorzata Kraszkiewicz, Agnieszka Namysł-Kaletka | PO-2047 | ESTRO | 2023
Stereotactic Body Re-irradiation for Bone Metastases
Laura Giannini, Federica Ferrario, Miriam Torrisi, Chiara Chissotti, Chiara Lucrezia Deantoni, Sara Broggi, Lucia Perna, Claudio Fiorino, Martina Midulla, Stefano Lorenzo Villa, Italo Dell’Oca, Andrei Fodor, Antonella Del Vecchio, Stefano Arcangeli, Nadia Gisella Di Muzio | PO-1596 | ESTRO | 2023
Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases
Federica Ferrario, Miriam Torrisi, Chiara Chissotti, Laura Giannini, Chiara Lucrezia Deantoni, Sara Broggi, Martina Midulla, Stefano Lorenzo Villa, Italo Dell’Oca, Andrei Fodor, Claudio Fiorino, Antonella Del Vecchio, Stefano Arcangeli, Nadia Gisella Di Muzio | PO-1595 | ESTRO | 2023
Stereotactic Salvage Radiotherapy for Prostate Bed Relapse, Early Analysis from a Prospective Trial
Giulio Francolini, Luca Burchini, Vanessa Di Cataldo, Beatrice Detti, Mauro Loi, Giulio Frosini, Barbara Guerrieri, Michele Ganovelli, Andrea Allegra, Viola Salvestrini, Luca Visani, Emanuela Olmetto, Carlotta Becherini, Gabriele Simontacchi, Manuele Roghi, Maria Grazia Carnevale, Isacco Desideri, Icro Meattini, Lorenzo Livi | PO-1459 | ESTRO | 2023
Stereotactic Focused Radiotherapy for Low-risk Prostate Cancer: Results of a Phase-II Trial
Paul Nguyen, Bertrand Donneaux, Céline Louis, Szusa Bodgal, Sven Philippi, Bérangère Frédérick, Sylvie Biver, Ludovic Harzé, Yves Lasar, Guillaume Vogin, Philippe Nickers | PO-1458 | ESTRO | 2023
Stereotactic APBI for Early-stage Breast Cancer: 3-year Outcomes of a Prospective Registry
Jonathan Cantalino, Monica Pernia Marin, David D’Ambrosio, Arica Hirsch, Malika Danner, Sonali Rudra, Simeng Suy, Sean Collins, Dawn Matsanka, Michael Good, Jing Feng, John Lamond, Deborah Markiewicz, Rachelle Lanciano, Olusola Obayomi-Davies, Brian Collins | PO-1249 | ESTRO | 2023
Stereotactic Reirradiation for Locally Recurrent Prostate Cancer after Definitive Radiotherapy
Giulio Francolini et al | PD-0576 | ESTRO | 2023
Dosimetric and Clinical Aspects of Lung SABR Delivered with Synchrony® Tracking on TomoTherapy
Marzia Cerrato et al | PD-0982 | ESTRO | 2023
Single-Fraction PSMA-PET- and Multiparametric MRI-Guided Focal SBRT for Prostate Cancer Local Recurrences
Felix Ehret et al | RSS | 2023
Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated Results
Christopher Mendez et al | RSS | 2023
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
Salvestrini V, Duijm M, Loi M, Nuyttens JJ | Cancers (Basel) | 2022
Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas – A randomized clinical trial
Marcin Miszczyk, Aleksandra Napieralska, Grzegorz Woźniak, Małgorzata Kraszkiewicz, Michał Gola, Michał Kalemba, Grzegorz Głowacki, Bartłomiej Tomasik, Magdalena Kocot-Kępska, Leszek Miszczyk | Radiother Oncol | 2022
2486: Correlation between Obesity and Treatment Failure Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer
D. Conroy, T. Sholklapper, M. K. K. Lawlor, J. M. Cantalino, A. Zwart, M. J. Ayoob, M. Danner, T. Yung, B. T. Collins, S. Lei, A. Rashid, D. Kumar, S. Suy, N. Aghdam, and S. P. Collins | ASTRO | 2022
194: Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial
K. P. Lui, K. Wang, R. C. Chen, B. L. Kane, C. A. Medbery III, K. Underhill Jr, J. R. Gray, A. V. Peddada, and D. B. Fuller | ASTRO | 2022
2026: Efficacy of SBRT in High Volume Metastatic Carcinoma Breast – A Berry Picking Approach in the Era of High Precision Radiotherapy
P.S. Sridhar, P. Anuradha, C. Fareena Taj, S. Suresh, K. Roopesh, R. Ghosh, S. Bj, | ASTRO | 2022
2031: Evaluation of Early Cosmetic Outcome and Toxicity after 5-Fraction Stereotactic Partial Breast Irradiation in Early-Stage Breast Cancer: A Prospective Cohort Study
H.K. Byun, J.S. Chang, H.J. Kim, J. Kim, M.C. Han, S.Y. KIM, R.H. PARK, C.J. Kim, and Y.B. Kim | ASTRO | 2022
3195: Real-World Dose Delivery Accuracy of Prostate SBRT with Tomotherapy Based Target Tracking
L. Goddard, J. Tang, M. K. Garg, W. R. Bodner III, P. Brodin, K. Jeong, and W. A. Tome | ASTRO | 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]